SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
CELLCOM ISRAEL LTD.
|
||
(Name of Issuer)
|
||
Ordinary Shares, NIS 0.01 par value
|
||
(Title of Class of Securities)
|
||
M2196U109
|
||
(CUSIP Number)
|
||
June 5, 2017
|
||
(Date of Event Which Requires Filing of this Statement)
|
1
|
NAMES OF REPORTING PERSONS/
|
|
|
||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
|||
Clal Insurance Enterprises Holdings Ltd.
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
(a)☐
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
PLACE OF ORGANIZATION
|
|
|
||
Israel
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
5,095,543 Ordinary Shares *
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
5,095,543 Ordinary Shares *
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
5,095,543 Ordinary Shares *
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
5.1%**
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON:
|
|
|
||
CO
|
|
|
|||
|
|
(a) |
Name of Issuer: CELLCOM ISRAEL LTD. (the “Issuer”).
|
(b) |
Address of Issuer’s Principal Executive Offices:
10 Hagavish Street, Netanya 4250708, Israel |
(a)
|
Name of Person Filing:
|
(b) |
Address of Principal Business Offices or, if none, Residence:
|
(c) |
Place of Organization:
|
(d) |
Title of Class of Securities:
|
(e) |
CUSIP Number:
|
Item 3. |
If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
Not applicable. |
Item 4. |
Ownership
|
1. |
IDB Development Corporation Ltd., an Israeli company (“IDB”), holds approximately 49.9% of the issued and outstanding shares of Clal. On August 21, 2013, the Israeli Supervisor of Capital Markets, Insurance and Savings (the “Supervisor of Insurance”) appointed Mr. Moshe Terry (the “Trustee”) to hold, as trustee, IDB’s means of control in Clal (i.e., most of the shares that IDB holds in Clal). The Supervisor of Insurance has not issued a control permit to IDB and its controlling shareholders, with respect to IDB’s holdings in Clal and instructed IDB to sell its controlling stake in Clal within a set timetable.
|
2. |
In accordance with IDB’s Report on Schedule 13D/A, filed with the SEC on October 22, 2015, IDB reported that it is the beneficial owner of approximately 45.2% of the outstanding Ordinary Shares of the Issuer and that it disclaims beneficial ownership of Ordinary Shares held by Clal at that time because, among other things, the Supervisor of Insurance appointed a trustee to hold IDB’s means of control in Clal and instructed IDB to dispose of its interest in Clal.
|
Item 5. |
Ownership of 5 Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐. |
Item 6. |
Ownership of More than 5 Percent on Behalf of Another Person
Not applicable. |
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
Not applicable. |
Item 8. |
Identification and Classification of Members of the Group
Not applicable. |
June 15, 2017
|
CLAL INSURANCE ENTERPRISES HOLDINGS LTD.
|
||
BY: /s/ Anath Levin /s/ Moshe Ernst
|
||
Anath Levin and Moshe Ernst, authorized signatories of
CLAL INSURANCE ENTERPRISES HOLDINGS LTD.
|